Clinical Trial Update: CARDIOLITE-413: A Study for Patients Who Had a PCI for an Acute MI [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial update for CARDIOLITE-413 involving patients who had PCI after an acute myocardial infarction; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• CARDIOLITE (TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE)

Snippet

Sponsor: Lantheus Medical Imaging | Conditions: Myocardial Infarction | Phase 4 | Status: COMPLETED